CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study | Zendy

David H. McDermott | Zendy; Qiong Yang | Zendy; Sekar Kathiresan | Zendy; L. Adrienne Cupples | Zendy; Joseph M. Massaro | Zendy; John F. Keaney | Zendy; Martin G. Larson | Zendy; Ramachandran S. Vasan | Zendy; Joel N. Hirschhorn | Zendy; Christopher J. O’Donnell | Zendy; Philip M. Murphy | Zendy; Emelia J. Benjamin | Zendy

Open Access

CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study

Author(s) -

David H. McDermott,

Qiong Yang,

Sekar Kathiresan,

L. Adrienne Cupples,

Joseph M. Massaro,

John F. Keaney,

Martin G. Larson,

Ramachandran S. Vasan,

Joel N. Hirschhorn,

Christopher J. O’Donnell,

Philip M. Murphy,

Emelia J. Benjamin

Publication year - 2005

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.543579

Subject(s) - medicine , myocardial infarction , framingham heart study , haplotype , linkage disequilibrium , allele , odds ratio , body mass index , cardiology , framingham risk score , genetics , biology , disease , gene

Monocyte chemoattractant protein-1 (MCP-1) is a chemokine strongly implicated in promoting atherosclerosis in animal models, but human genetic evidence is contradictory.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research